Company Historically Provides H1B Sponsorship
Teladoc Health provides virtual care worldwide via an integrated telehealth platform that connects patients with providers for both episodic visits and ongoing chronic condition management. It operates a multi-brand model, including BetterHelp, Livongo, and InTouch Health, with revenue from subscriptions often paid by employers or health plans and per-visit fees for individual consultations. The platform combines evidence-based care with real-time data and cross-setting clinical collaboration, serving both consumer and enterprise needs. Its goal is to improve access to high-quality, personalized healthcare for diverse populations by removing barriers and supporting continuous digital health engagement.
Work here?Claim your company
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
2002
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$605.2M
Above
Industry Average
Funded Over
9 Rounds
Teladoc Health has launched two AI-powered features for its Solo connected care platform to help hospitals streamline clinical workflows. SoloVitals uses remote photoplethysmography technology to capture heart rate and respiration rate contactless through a patient's camera-equipped device by analyzing facial skin color changes. SoloScribe provides ambient AI documentation that creates structured clinical notes during virtual visits, reducing administrative burden on clinicians. Both capabilities integrate directly into Solo's platform, which is installed in over 15,000 care locations globally. The platform offers deep integrations with EHR systems including Epic and Oracle Health using HL7 and FHIR standards. SoloScribe is now generally available, whilst SoloVitals is in private preview with full release expected in December 2026.
Teladoc Health announces Chief Legal Officer transition. Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026. NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer and Secretary, has informed the company of his decision to resign, effective November 1, 2026. Jonathan Dorfman, Teladoc Health's current Senior Vice President, Securities and Corporate Law, will succeed Vandervoort and be promoted to Chief Legal Officer and Secretary effective November 2, 2026. Since joining Teladoc Health in 2015, Vandervoort has helped guide the company through its initial public offering, the rapid acceleration of virtual care adoption during the pandemic and an evolving regulatory landscape. "For more than a decade, Adam has been a trusted partner to Teladoc Health's leadership team, helping advance our mission and increase our impact," said Chuck Divita, Chief Executive Officer of Teladoc Health. "His leadership has strengthened our company and helped establish a foundation for the broader virtual care industry. We are grateful for Adam's many contributions and for his support through this transition." Dorfman joined Teladoc Health in 2020 through the acquisition of Livongo, where he led SEC compliance and corporate governance. He has served in legal roles of increasing responsibility at Teladoc Health, most recently leading the company's SEC reporting and disclosure, corporate governance, capital markets and mergers and acquisitions. Previously, Dorfman was an in-house lawyer at USG Corporation and practiced law at Sidley Austin LLP. "Jonathan is a proven leader who has earned the trust of our Board and leadership team," Divita said. "His expertise, judgment and deep understanding of our business make him the natural choice to succeed Adam, and his promotion reflects the strength of the team Adam built." "I am honored to take on this role and grateful to Adam for the strong foundation he has built," said Dorfman. "I look forward to working with our talented colleagues to support Teladoc Health's mission and the people we serve." Dorfman holds a Juris Doctor from Northwestern University Pritzker School of Law and a Bachelor of Business Administration from the University of Michigan's Stephen M. Ross School of Business. About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms and partners - transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Teladoc Health reported Q2 revenues of $606.9 million, down 4% year-on-year and missing analysts' expectations by 1.3%. The telemedicine platform, which facilitates remote doctor consultations, delivered the weakest performance among 11 tracked online marketplace stocks. Chief Executive Officer Chuck Divita said the company is progressing on priorities important to its long-term success, with results within guidance ranges on a consolidated basis. However, the quarter showed distinct dynamics across Teladoc's two segments. The company's revenue and EBITDA guidance for the next quarter significantly missed analysts' expectations. Following the results, Teladoc's share price fell 28.2%, currently trading at $6.59. The online marketplace sector collectively saw revenues beat consensus estimates by 1.9% in Q2, though share prices have declined 5% on average since earnings.
Teladoc Health has announced employment inducement awards for its new chief financial officer, Michael Grasher. The global virtual care leader granted Grasher restricted stock units covering 239,616 shares of common stock, along with performance stock units covering a target of 239,616 shares, with up to 479,232 shares potentially earnable. The restricted stock units vest over time, beginning with one-half of shares on the first anniversary of the 1 September 2026 grant date. The performance stock units are tied to Teladoc Health's adjusted EBITDA for 2026 and its compound annual revenue growth rate during 2026-2028. The awards were approved by the company's compensation committee under the 2023 Employment Inducement Incentive Award Plan, pursuant to New York Stock Exchange Rule 303A.08.
Teladoc Health has appointed Michael Grasher as chief financial officer, bringing in an insurance industry veteran as the virtual healthcare company grapples with capacity challenges in its mental health services unit. The appointment comes a month after Teladoc reduced its annual revenue forecast, citing difficulties at BetterHelp, where demand for insurance-covered therapy has exceeded available provider capacity. Grasher brings over 30 years of experience in insurance and financial services, having served in CFO roles for more than 12 years. He most recently held the CFO position at IFG Companies, a privately held property-casualty insurance organisation. Evercore ISI analyst Elizabeth Anderson called the appointment "an important step in solidifying" Teladoc's leadership team following former CFO Mala Murthy's departure in November 2025.
Find jobs on Simplify and start your career today
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
2002
Find jobs on Simplify and start your career today